Stop Superbugs Act

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 5237 Introduced in Senate (IS)]

<DOC>

119th CONGRESS 2d Session S. 5237

To require the Director of the National Institute of Allergy and Infectious Diseases to award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, and for other purposes.

_______________________________________________________________________

IN THE SENATE OF THE UNITED STATES

August 4, 2026

Ms. Hassan (for herself and Mr. Marshall) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

A BILL

To require the Director of the National Institute of Allergy and Infectious Diseases to award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ``Stop Superbugs Act''.

SEC. 2. FUNDING FOR ANTIBIOTIC RESISTANCE CLINICAL RESEARCH.

(a) In General.--The Director of the National Institute of Allergy and Infectious Diseases shall award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, which shall include focuses on-- (1) supporting rapid recruitment of clinical trial participants; (2) conducting clinical trial recruitment outreach in community settings; (3) supporting the pairing of diagnostic and pharmaceutical innovations during clinical trials; and (4) developing patient-reported outcomes in clinical studies. (b) Authorization of Appropriations.--There is authorized to be appropriated to the Director of the National Institute of Allergy and Infectious Diseases such sums as may be necessary to carry out subsection (a). <all>